OC-0201: Hodgkin Lymphoma patients treated with IMRT: from dosimetric analysis to cardiovascular disease risk. (November 2020) - Orlandi, E.; De Luca, V.; Gallio, E.; Bartoncini, S.; Iorio, G.C.; Parise, R.; Cavallin, C.; Palladino, C.; Fiandra, C.; Levis, M.; Ricardi, U.